Search alternatives:
point decrease » point increase (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 mg » 10 mm (Expand Search)
point decrease » point increase (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), mean decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
10 mg » 10 mm (Expand Search)
-
721
-
722
Structure model predictions of wildtype and A398E/V and M1425V/I Ca<sub>V</sub>3.3 channels.
Published 2025Subjects: -
723
-
724
-
725
-
726
-
727
-
728
-
729
-
730
-
731
-
732
N protein of SVCV decreases K48-linked ubiquitination of p53.
Published 2019“…<b>(D)</b> N protein decreases the ubiquitination of p53. EPC cells were seeded in 10 cm<sup>2</sup> dishes and transfected with 5 μg p53-Myc, 5 μg N-Flag or empty vector, and 1 μg HA-Ub. …”
-
733
Mefunidone decreased collagen I, collagen III, α-smooth muscle actin (α-SMA) and fibronectin (FN) expression in the obstructive kidneys after UUO at 14 days.
Published 2015“…<p><b><i>A</i>.</b> Mefunidone affected collagen I (left) and collagen III (right) protein expression in the obstructed kidneys stained by immunohistochemistry (×200). …”
-
734
-
735
-
736
-
737
Cellular stress decreases TDP-43 levels in patient neurons with the TDP-43 A90V mutation.
Published 2013Subjects: -
738
-
739
EphA4 immunostaining is decreased adjacent to injury site in ephrin-A5-Fc treated mice.
Published 2011“…<p>Immunohistochemical analysis of (A,B) GFAP, (C–F) EphA4 and (G,H) CSPG expression at 2 weeks after spinal cord hemisection and 2 weeks of ephrin-A5-Fc treatment indicated that there was robust GFAP staining in both treated and control mice (A,B). …”
-
740